STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader

Good morning. I have a gallon of apple cider I don’t know what to do with. Please send any good recipes you have!

The need-to-know this morning

  • Moderna appointed Juan Andres as its new chief operating officer, a new executive role for the company as it prepares to expand into oncology. This is Andres’ second stint with Moderna. He previously served as its top executive in charge of manufacturing and quality control.Ā 
  • Pierre Fabre Pharmaceuticals and Atara Biotherapeutics said their drug Ebvallo was refiled with the FDA. The companies areĀ seeking approval to treat patients with an ultra-rare and fatal type of blood cancer that can develop in people who have received a stem cell or solid organ transplant. In May, the FDA agreed to review Ebvallo again after previously rejecting the drug.Ā 

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks